000000342 001__ 342
000000342 005__ 20231130114548.0
000000342 0247_ $$2DOI$$a10.6083/M4P26W2N
000000342 037__ $$aETD
000000342 245__ $$aCharacterization of prothrombotic pathways in vivo, and discovery of potential new therapies for pathological blood coagulation
000000342 260__ $$bOregon Health and Science University
000000342 269__ $$a2009
000000342 336__ $$aDissertation
000000342 502__ $$bPh.D.
000000342 540__ $$fCC BY
000000342 542__ $$fIn copyright - single owner
000000342 650__ $$aAspirin$$015160
000000342 650__ $$aThrombosis$$027034
000000342 650__ $$aBlood Platelets$$015667
000000342 650__ $$aSepsis$$031109
000000342 650__ $$aBlood Coagulation Factors$$015654
000000342 6531_ $$ableeding
000000342 6531_ $$afactor x1
000000342 6531_ $$aplatelets
000000342 691__ $$aSchool of Medicine$$041369
000000342 692__ $$aDepartment of Science and Engineering$$041447
000000342 7001_ $$aTucker, Erik I.
000000342 7001_ $$uOregon Health and Science University$$041354
000000342 8564_ $$9fa1b2dbe-96e7-460f-b6ee-3df996eb0a57$$s1904835$$uhttps://digitalcollections.ohsu.edu/record/342/files/343_etd.pdf
000000342 905__ $$a/rest/prod/z3/16/q1/58/z316q158b
000000342 909CO $$ooai:digitalcollections.ohsu.edu:342$$pstudent-work
000000342 980__ $$aTheses and Dissertations